Abstract:During our life, we are surrounded by continuous threats from a diverse range of invading pathogens. Our immune system has evolved multiple mechanisms to efficiently deal with these threats so as to prevent them from causing disease. Terminal differentiation of mature B cells into plasma cells (PC) - the antibody (Ab) secreting cells of the immune system - is critical for the generation of protective and long-lived humoral immune responses. Indeed, efficient production of antigen (Ag)-specific Ab by activated B cells underlies the success of most currently available vaccines. The mature B-cell pool is composed of several subsets, distinguished from one according to size, surface marker expression, location, and Ag exposure, and they all have the capacity to differentiate into PCs. For a B-cell to acquire the capacity to produce Abs, it must undergo an extensive differentiation process driven by changes in gene expression. Two broad categories of Ags exist that cause B-cell activation and differentiation: T cell dependent (TD) or T cell independent (TI). In addition to the B-cell subset and nature of the Ag, it is important to consider the cytokine environment that can also influence how B-cell differentiation is achieved. Thus, while many cytokines can induce Ab-secretion by B cells after activation with mimics of TD and TI stimuli in vitro, they can have different efficacies and specificities, and can often preferentially induce production of one particular Ig isotype over another. Here, we will provide an overview of in vitro studies (mouse and human origin) that evaluated the role of different cytokines in inducing the differentiation of distinct B-cell subsets to the PC lineage. We will place particular emphasis on IL-21, which has emerged as the most potent inducer of terminal B-cell differentiation in humans. We will also focus on the role of IL-21 and defects in B-cell function and how these contribute to human immunopathologies such as primary immunodeficiencies and B-cell mediated autoimmune conditions.

IL-23 Promotes a Coordinated B Cell Germinal Center Program for Class-Switch Recombination to IgG2b in BXD2 Mice

An Interleukin 9-Zbtb18 Axis Promotes Germinal Center Development of Memory B Cells

IL-21R signal reprogramming cooperates with CD40 and BCR signals to select and differentiate germinal center B cells

Polyclonal Hyper-Ige Mouse Model Reveals Mechanistic Insights into Antibody Class Switch Recombination.

T-cell help in the germinal center: homing in on the role of IL-21

Heparan Sulfate Regulates IL-21 Bioavailability and Signal Strength That Control Germinal Center B Cell Selection and Differentiation.

Increased targeting of donor switch region and IgE in Sgamma1-deficient B cells.

In vivo Screen Identifies Zdhhc2 as a Critical Regulator of Germinal Center B Cell Differentiation.

IL-21 Shapes the B Cell Response in a Context-Dependent Manner

Increased Targeting of Donor Switch Region and IgE in Sγ1-Deficient B Cells

Interleukin-4 downregulates transcription factor BCL6 to promote memory B cell selection in germinal centers

IgD Class Switching is Initiated by Microbiota and Limited to Mucosa-Associated Lymphoid Tissue in Mice

The miR-1792 miRNAs promote plasma cell differentiation by suppressing SOCS3-mediated NIK degradation

MiR-17~92 family microRNAs are critical regulators of T follicular helper cell differentiation (P1133)

Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage

Suppression of Human and Mouse Th17 Differentiation and Autoimmunity by an Endogenous Interleukin 23 Receptor Cytokine-Binding Homology Region

IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation

A Regulatory Role for IL-10 Receptor Signaling in Development and B Cell Help of T Follicular Helper Cells in Mice

The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers.

PTEN-Regulated AID Transcription in Germinal Center B Cells is Essential for the Class-Switch Recombination and IgG Antibody Responses

TGF-β specifies T FH versus T H 17 cell fates in murine CD4 + T cells through c-Maf